Can We Afford Personalized Medicine? Special treatment for ‘high profile’ patients; exasperation for the rest of us Health Insurers Making Record Profits as Many Postpone Care People Who Donate Organs For Transplants Can Have Difficulty Getting Insurance Foundations, Conflicts Of Interest And Drugmakers Mission Crash: The Intolerable Policy Incoherence in US AIDS Policy, Global and [...]
Archive for the ‘Health Insurance’ Category
Headline Scan
Posted in Access to Medicines, Advocacy, Assistance, Children's Health, Economics of Health Care, Environmental Health, Ethics, Global Health, Health Care Marketing, Health Disparities, Health Insurance, Health Literacy, Healthcare Inequalities, Language Access, Recession, State of Washington, Workers' rights on 18 May 2011 | Leave a Comment »
Another drug price story that defies logic
Posted in Access to Medicines, Consumer Protection, Economics of Health Care, Ethics, Health Care Marketing, Health Insurance on 15 December 2010 | Leave a Comment »
A friend recently shared this personal story with me, in the hopes that it will inspire people to demand price controls on drugs, as well as an end to the Rx profiteering by insurance companies. This is a story about a commonly-prescribed generic drug, levothyroxine, used for hypothyroidism and other thyroid conditions. The fact that [...]
NLARx Alert:Immediate Action Needed to Preserve State Medicaid Prescription Drug Rebates
Posted in Access to Medicines, Economics of Health Care, Health Care Reform, Health Insurance on 27 July 2010 | Leave a Comment »
During the first week of July, an action alert was sent out by the National Legislative Association on Prescription Drug Prices (NLARx) about the need for states to take immediate action on this. The full memo can be read via the link on the Pharmaceuticals and Healthcare Reform page of the NLARx website . Among [...]
In the News
Posted in Access to Medicines, Discrimination, Economics of Health Care, Ethics, Health Care Marketing, Health Care Reform, Health Insurance on 25 April 2010 | Leave a Comment »
Drug Prices Rose 9.1% Last Year, Ahead of Federal Health Overhaul Drug companies sharply raised prices last year, ahead of increased rebates they must pay to Medicaid and other expenses tied to the federal health overhaul passed last month. WellPoint routinely targets breast cancer patients Shortly after they were diagnosed with breast cancer, each of [...]
Patient has emergency surgery, insurer nixes hospital stay
Posted in Health Insurance, tagged Mindless bureaucracy, Profit motive on 27 January 2010 | Leave a Comment »
Those of us who have been immersed in advocacy work for a long time often think that no healthcare horror story can shock us any more. Wrong! This is the story of a patient fortunate to again be employed and insured through work, but who, like most Americans, is living only a few paychecks away [...]
